The effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/μL in a public health setting
about
When to start antiretroviral therapy: as soon as possibleA text messaging intervention to improve retention in care and virologic suppression in a U.S. urban safety-net HIV clinic: study protocol for the Connect4Care (C4C) randomized controlled trialImpact of geographic and transportation-related barriers on HIV outcomes in sub-Saharan Africa: a systematic review.Community-based harm reduction substance abuse treatment with methamphetamine-using men who have sex with men.Linkage to HIV care in San Francisco: implications of measure selectionTiming of antiretroviral therapy initiation in a nationally representative sample of HIV-infected adults receiving medical care in the United States.Impact of Age and Sex on CD4+ Cell Count Trajectories following Treatment Initiation: An Analysis of the Tanzanian HIV Treatment Database.Retention in care within 1 year of initial HIV care visit in a multisite US cohort: who's in and who's out?Measuring the unknown: calculating community viral load among HIV-infected MSM unaware of their HIV status in San Francisco from National HIV Behavioral Surveillance, 2004-2011.High-dose valacyclovir decreases plasma HIV-1 RNA more than standard-dose acyclovir in persons coinfected with HIV-1 and HSV-2: a randomized crossover trial.Loss to follow-up occurs at all stages in the diagnostic and follow-up period among HIV-infected patients in Guinea-Bissau: a 7-year retrospective cohort studyIncidences and risk factors of first-line HAART discontinuation: a limitation to the success of the "seek, test, treat, and retain" strategy?The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting.Postpartum Engagement in HIV Care: An Important Predictor of Long-term Retention in Care and Viral Suppression.A Randomized Controlled Trial of a Text Messaging Intervention to Promote Virologic Suppression and Retention in Care in an Urban Safety-Net HIV Clinic: The Connect4Care (C4C) Trial.
P2860
Q27006767-F75B82D4-D16F-46BE-BC21-59B8F948B129Q30620093-CB250D6C-5740-4BEF-8729-89F6A249A5ACQ33717359-60C45515-3479-433E-A16C-95520806489EQ33818293-A329B8B2-DA3E-4030-99A8-FDA8B864B068Q33834704-46AD958B-67B6-4046-B2D8-B4FD0A3967D0Q34606589-463BFC38-A69C-459B-B629-EBE006023375Q36157659-8AE3DA87-6480-4140-B84E-103DBC19FBEFQ36311761-80884878-DC4E-4CEC-B238-81F42B282C05Q36845260-FC2D8CBD-3A52-4551-9FED-92F0BC46D326Q37081751-608FFC2F-3831-4384-A64A-8C46E6C4CE30Q37256464-0B91EF0F-CC3F-4CEF-9DB3-1B7851F37A87Q38422291-B54CFC1C-E39A-4863-A544-B1207478E337Q40607885-1FC3F6A6-4AAF-4508-80C9-F538F914F9BDQ41057438-0D1F3B39-45C7-424A-B7A9-278BFF7EB64AQ54267691-95D6EB97-135A-45B0-AB15-2B899FCBBFD6
P2860
The effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/μL in a public health setting
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The effect of a "universal ant ...... /μL in a public health setting
@ast
The effect of a "universal ant ...... /μL in a public health setting
@en
The effect of a "universal ant ...... /μL in a public health setting
@nl
type
label
The effect of a "universal ant ...... /μL in a public health setting
@ast
The effect of a "universal ant ...... /μL in a public health setting
@en
The effect of a "universal ant ...... /μL in a public health setting
@nl
prefLabel
The effect of a "universal ant ...... /μL in a public health setting
@ast
The effect of a "universal ant ...... /μL in a public health setting
@en
The effect of a "universal ant ...... /μL in a public health setting
@nl
P2093
P2860
P356
P1476
The effect of a "universal ant ...... /μL in a public health setting
@en
P2093
C Bradley Hare
Elvin H Geng
James O Kahn
Katerina A Christopoulos
Monica Gandhi
Tracy Van Nunnery
Vivek Jain
P2860
P304
P356
10.1093/CID/CIS750
P407
P577
2012-09-05T00:00:00Z